Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
GSK settlement keeps it on course to remove Zantac overhang by early 2024, analyst says
08:44am, Thursday, 12'th Oct 2023
GSK PLC's (LSE:GSK, NYSE:GSK) latest out-of-court Zantac deal is important to the ongoing "overhang" over the investment case, Citigroup said. The US investment bank reiterated its belief that the F
Why GSK (GSK) Outpaced the Stock Market Today
08:18pm, Wednesday, 11'th Oct 2023
In the most recent trading session, GSK (GSK) closed at $37.56, indicating a +0.59% shift from the previous trading day.
Startup Cerebras stands out in the high-risk AI chip arena: ‘No one has built a chip this big'
07:44pm, Wednesday, 11'th Oct 2023
While most computer-chip makers over the past decades have touted the benefits of an ever-shrinking product, a well-funded Silicon Valley company has built what it says is the largest and fastest-ever
GSK Settles Zantac Cases After Claims Popular Heartburn Drug Causes Cancer
08:30am, Wednesday, 11'th Oct 2023
The pharma giant settled four cases in California for an undisclosed amount to avoid the “distraction” of a trial.
GSK strikes legal settlement over heartburn drug Zantac
02:24am, Wednesday, 11'th Oct 2023
GSK PLC (LSE:GSK, NYSE:GSK) has struck a deal to stop a high profile case concerning its heartburn drug Zantac heading to court in California. The FTSE 100-listed pharma giant said it had reached a co
GSK reaches confidential settlement in California Zantac lawsuit
02:13am, Wednesday, 11'th Oct 2023
GSK on Wednesday said it had reached a confidential settlement on a litigation in California over claims that the British drugmaker's heartburn drug Zantac caused cancer.
GSK (GSK) Surpasses Market Returns: Some Facts Worth Knowing
07:32pm, Monday, 09'th Oct 2023
GSK (GSK) closed at $37.10 in the latest trading session, marking a +1.23% move from the prior day.
GSK inks £2.5bn shingles vaccine deal with China's Zhifei
03:12am, Monday, 09'th Oct 2023
GSK PLC (LSE:GSK, NYSE:GSK) has inked an exclusive three-year agreement, £2.5 billion with China's Zhifei to co-promote its shingles vaccine in China. With an option for extension, this strategic d
GSK signs shingles vaccine deal with China's Zhifei for about $3 bln
02:18am, Monday, 09'th Oct 2023
GSK , on Monday, announced an exclusive partnership with China's Chongqing Zhifei Biological Products (Zhifei) for its shingles vaccine.
GSK reportedly set to shake up R&D opertion
02:14am, Monday, 09'th Oct 2023
GSK PLC (LSE:GSK, NYSE:GSK) is set to restructure its research division, impacting scientists in the UK, the US, and Belgium, according to the Sunday Times. The pharmaceutical giant aims to replace it
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
10:32am, Friday, 06'th Oct 2023
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Nobel for mRNA: Which other biotech stocks might be overlooked?
08:33am, Friday, 06'th Oct 2023
Scientists Katalin Karikó and Drew Weissman were awarded the Nobel prize this week for a discovery that went under the radar for many years, until it was found to hold the key to stabilising mRNA v
GSK banks almost £900m for Haleon stake sale
03:03am, Friday, 06'th Oct 2023
GSK PLC (LSE:GSK, NYSE:GSK) has further reduced its stake in consumer health group Haleon PLC (LSE:HLN, NYSE:HLN), offloading 270 million shares for around £886 million. It is the second time in thre
GSK raises 886 mln pounds from Haleon stake sale
02:20am, Friday, 06'th Oct 2023
British drugmaker GSK on Friday said it raised 885.6 million pounds ($1.08 billion) from a stake sale in its spun-off consumer healthcare business Haleon at 328 pence a piece.
Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report?
01:31pm, Wednesday, 04'th Oct 2023
Glaxo (GSK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
